Market Cap

Diamyd Medical AB Market Capitalization:

kr1.34 Billion

SEK as of July 1, 2024

US$126.1 Million

business Diamyd Medical AB Company Profile

Diamyd Medical AB Main Stock Listing

OMX: DMYD.B

Market Capitalization History of Diamyd Medical AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Diamyd Medical AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr653.7 M -46.01%
Jan. 1, 2023 kr1.21 B -9.65%
Jan. 1, 2022 kr1.34 B -36.90%
Jan. 1, 2021 kr2.12 B 46.49%
Jan. 1, 2020 kr1.45 B 141.51%
Jan. 1, 2019 kr600.3 M 98.45%
Jan. 1, 2018 kr302.5 M -28.68%
Jan. 1, 2017 kr424.1 M 33.12%
Jan. 1, 2016 kr318.6 M -0.96%
Jan. 1, 2015 kr321.7 M 30.00%
Jan. 1, 2014 kr247.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Diamyd Medical AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Diamyd Medical AB has the following listings and related stock indices.


Stock: OMX: DMYD.B

Stock: FSX: DMN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.